Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1996-11-27
pubmed:abstractText
Percutaneous balloon mitral valvuloplasty (PBMV) is an effective means of palliating mitral stenosis, but it sometimes leads to adverse clinical outcomes and exorbitant in-hospital costs. Because echocardiographic score is known to be predictive of clinical outcome in patients undergoing PBMV, we examined whether it could also be used to predict in-hospital cost. Preprocedure echocardiographic scores, baseline clinical characteristics, and total in-hospital costs were examined among 45 patients who underwent PBMV between January 1, 1992, and January 1, 1994. Patients ranged in age from 18 to 71 years and had preprocedure echocardiographic scores that ranged from 4 to 12. Following PBMV, mean mitral valve area increased from 1.1 +/- 0.3 to 2.4 +/- 0.6 cm2 (p = 0.0001), and mean pressure gradient decreased from 18.3 +/- 5.9 to 6.7 +/- 2.7 mm Hg (p = 0.0001). In-hospital cost for the 45 patients ranged from $3,591 to $70,975 (mean $9,417; median $5,311). Univariate and multiple linear regression analyses demonstrated that among the variables examined, echocardiographic score (p = 0.0007), age (p = 0.01), and preprocedure mitral valve gradient (p = 0.03) were associated with in-hospital cost. Regression modeling suggested that every increase in preprocedure echocardiographic score of one grade was associated with an increase in in-hospital cost of $2,663. Because echocardiographic score is predictive of both clinical outcome and in-hospital cost, we conclude that patients with elevated scores should be considered for alternative therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0002-9149
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
790-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:8857484-Adolescent, pubmed-meshheading:8857484-Adult, pubmed-meshheading:8857484-Aged, pubmed-meshheading:8857484-Balloon Dilation, pubmed-meshheading:8857484-Cost Control, pubmed-meshheading:8857484-Echocardiography, pubmed-meshheading:8857484-Female, pubmed-meshheading:8857484-Health Care Costs, pubmed-meshheading:8857484-Heart Diseases, pubmed-meshheading:8857484-Hospitalization, pubmed-meshheading:8857484-Humans, pubmed-meshheading:8857484-Linear Models, pubmed-meshheading:8857484-Male, pubmed-meshheading:8857484-Middle Aged, pubmed-meshheading:8857484-Mitral Valve Stenosis, pubmed-meshheading:8857484-Multivariate Analysis, pubmed-meshheading:8857484-Odds Ratio, pubmed-meshheading:8857484-Predictive Value of Tests, pubmed-meshheading:8857484-Regression Analysis, pubmed-meshheading:8857484-Sensitivity and Specificity, pubmed-meshheading:8857484-Surgical Procedures, Operative
pubmed:year
1996
pubmed:articleTitle
Echocardiographic score as a predictor of in-hospital cost in patients undergoing percutaneous balloon mitral valvuloplasty.
pubmed:affiliation
Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.
pubmed:publicationType
Journal Article